Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
European Federation of Neurological Societies; Peripheral Nerve Society; Hadden RD, Nobile-Orazio E, Sommer C, Hahn A, Illa I, Morra E, Pollard J, Hughes RA, Bouche P, Cornblath D, Evers E, Koski CL, Léger JM, Van den Bergh P, van Doorn P, van Schaik IN. European Federation of Neurological Societies, et al. Among authors: cornblath d. Eur J Neurol. 2006 Aug;13(8):809-18. doi: 10.1111/j.1468-1331.2006.01467.x. Eur J Neurol. 2006. PMID: 16879290
Guillain-Barré syndrome: the evolution of therapy.
Cornblath DR, Hughes RA. Cornblath DR, et al. J Neurol. 1994 May;241(6):404-5. doi: 10.1007/BF02033360. J Neurol. 1994. PMID: 7931438 Clinical Trial. No abstract available.
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome.
Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV; Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Hadden RD, et al. Among authors: cornblath dr. Neurology. 2001 Mar 27;56(6):758-65. doi: 10.1212/wnl.56.6.758. Neurology. 2001. PMID: 11274311 Clinical Trial.
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Hughes RA, Wijdicks EF, Barohn R, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Miller RG, Sladky JT, Stevens JC; Quality Standards Subcommittee of the American Academy of Neurology. Hughes RA, et al. Among authors: cornblath dr. Neurology. 2003 Sep 23;61(6):736-40. doi: 10.1212/wnl.61.6.736. Neurology. 2003. PMID: 14504313
Supportive care for patients with Guillain-Barré syndrome.
Hughes RA, Wijdicks EF, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Sladky JT, Barohn RJ, Stevens JC; Multidisciplinary Consensus Group. Hughes RA, et al. Arch Neurol. 2005 Aug;62(8):1194-8. doi: 10.1001/archneur.62.8.1194. Arch Neurol. 2005. PMID: 16087757
Guillain-Barré syndrome.
Hughes RA, Cornblath DR. Hughes RA, et al. Lancet. 2005 Nov 5;366(9497):1653-66. doi: 10.1016/S0140-6736(05)67665-9. Lancet. 2005. PMID: 16271648 Review.
282 results